Across TCGA pan-cancer cohorts, RNA5SP407 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNA5SP407 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RNA5SP407 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNA5SP407 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

SKCM, STAD, and OV are the cancer types where RNA5SP407 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	All	0.058	0.757	<.001	54	view →
STAD	DFS	Tertile	II,III,IV	0.228	0.617	.009	36	view →
OV	OS	Tertile	III,IV	0.790	0.673	.023	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RNA5SP407 tumor-vs-normal RNA expression · all RNA5SP407 data types